GoodRx Holdings Financials - Benzinga

GoodRx Holdings Inc

GDRXNASDAQ

Trade with Public

Trade with Public

$3.36

0.041.2%

近くで: Sep 24, 5:00 PM EST

$3.36

N/A

時間外: 4:26 PM EST

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

GoodRx Holdings Financials

GoodRx Holdings (GDRX) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
GoodRx Holdings Raises FY2026 Sales Guidance from $765.000M-$785.000M to $790.000M-$805.000M vs $775.751M Est

GoodRx Holdings (NASDAQ:GDRX) raises FY2026 sales outlook from $765.000 million-$785.000 million to $790.000 million-$805.000 million vs $775.751 million estimate.

Benzinga Newsdesk

PRO
GoodRx Holdings Q2 Adj. EPS $0.08, Inline, Sales $200.411M Beat $193.162M Estimate

GoodRx Holdings (NASDAQ:GDRX) reported quarterly earnings of $0.08 per share which met the analyst consensus estimate. This is a 11.11 percent decrease over earnings of $0.09 per share from the same period last year.

Benzinga Newsdesk

Earnings Scheduled For May 6, 2026

Benzinga Insights

PRO
GoodRx Holdings Raises FY2026 Sales Guidance from $750.000M-$780.000M to $765.000M-$785.000M vs $764.443M Est

GoodRx Holdings (NASDAQ:GDRX) raises FY2026 sales outlook from $750.000 million-$780.000 million to $765.000 million-$785.000 million vs $764.443 million estimate.

Benzinga Newsdesk

PRO
GoodRx Holdings Q1 Adj. EPS $0.07, Inline, Sales $194.006M Beat $185.137M Estimate

GoodRx Holdings (NASDAQ:GDRX) reported quarterly earnings of $0.07 per share which met the analyst consensus estimate. This is a 22.22 percent decrease over earnings of $0.09 per share from the same period last year.

Benzinga Newsdesk

PRO
GoodRx Holdings Sees FY2026 Sales $750.000M-$780.000M vs $815.142M Est

Benzinga Newsdesk

© 2026 Benzinga | All Rights Reserved